Home / Resource Library / Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches – Focus on EZH2-Targeted Drugs

Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches – Focus on EZH2-Targeted Drugs

Study examined EZH2 mutations as a therapeutic target in the treatment of follicular lymphoma.